Moody National Bank Trust Division Invests $740,000 in Acadia Healthcare Company, Inc. $ACHC

Posted by on Aug 6th, 2026

Moody National Bank Trust Division bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 25,063 shares of the company’s stock, valued at approximately $740,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare during the first quarter valued at approximately $1,600,000. Goldman Sachs Group Inc. lifted its holdings in shares of Acadia Healthcare by 21.1% in the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Acadia Healthcare by 8.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after acquiring an additional 27,207 shares during the last quarter. American Century Companies Inc. grew its stake in Acadia Healthcare by 531.5% during the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after acquiring an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. grew its stake in Acadia Healthcare by 21.9% during the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after acquiring an additional 1,780 shares in the last quarter.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $32.24 on Thursday. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of -2.59, a PEG ratio of 10.28 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The business has a 50 day simple moving average of $28.71 and a 200-day simple moving average of $24.22. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

Analysts Set New Price Targets

ACHC has been the topic of several research analyst reports. Guggenheim boosted their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Royal Bank Of Canada increased their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. TD Cowen lifted their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $29.85.

View Our Latest Stock Report on ACHC

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Featured Articles

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.